Preferred Label : Pembrolizumab Regimen;
NCIt synonyms : Keytruda Regimen;
NCIt related terms : Pembrolizumab monotherapy;
NCIt definition : A regimen consisting of pembrolizumab that may be used in the treatment of anal, anaplastic,
Merkel cell, and thymic carcinomas; ampullary, appendiceal, pancreatic, and small
bowel adenocarcinomas; alveolar soft part sarcoma; soft tissue sarcoma; bladder, breast,
esophageal and esophagogastric junction, kidney, occult primary, gastric, bone, colorectal,
cervical, non-small cell lung, small cell lung, penile, testicular, prostate, hepatobiliary,
endometrial, and vulvar, and ovarian, fallopian tube and primary peritoneal cancers;
head and neck cancer including cancer of the nasopharynx; gestational trophoblastic
neoplasia; chronic lymphocytic leukemia (CLL); small lymphocytic lymphoma (SLL); diffuse
large B-cell lymphoma (DLBCL); Hodgkin lymphoma; T-cell lymphomas; mycosis fungoides/Sezary
syndrome; follicular, medullary, papillary and Hurthle cell thyroid carcinomas; malignant
germ cell tumors; adrenal gland and neuroendocrine tumors (NETs); extrapulmonary poorly
differentiated neuroendocrine carcinoma, large or small cell carcinoma, and mixed
neuroendocrine-non-neuroendocrine neoplasm; squamous cell skin cancer; and cutaneous
and uveal melanoma.;
NCI Metathesaurus CUI : CL969182;
Codes from synonyms : 3199;
Origin ID : C160108;
UMLS CUI : C5204945;
Semantic type(s)
- chemotherapy_regimen_has_component
- concept_is_in_subset
https://pgtmsite.files.wordpress.com/2024/01/protocole-ad-pembrolizumab_final.pdf
2020
Canada
drug information
pembrolizumab
pembrolizumab
pembrolizumab
Pembrolizumab Regimen
AD Regimen
---
